All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy
Elanco Animal Health (ELAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript
Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Elanco Animal Health Incorporated (ELAN) Q3 2025 Earnings Call Transcript
Elanco Animal Health Incorporated ( ELAN ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Tiffany Kanaga Jeffrey Simmons - President, CEO & Director Robert VanHimbergen - Executive VP & CFO Conference Call Participants Umer Raffat - Evercore ISI Institutional Equities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Andrea Zayco Narvaez Alfonso - UBS Investment Bank, Research Division Michael Ryskin - BofA Securities, Research Division Linda Bolduc - Morgan Stanley, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Navann Ty Dietschi - BNP Paribas, Research Division Andrew Dusing - Cleveland Research Company LLC Presentation Operator Ladies and gentlemen, thank you for standing by.
Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics
The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.13 per share a year ago.
Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment
Health and Human Services Secretary Robert F. Kennedy Jr. determined that New World screwworm presents significant potential for a public health emergency.
Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy?
Does Elanco Animal Health Incorporated (ELAN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock?
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript
Elanco Animal Health Incorporated (NYSE:ELAN ) Q2 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Jeffrey N. Simmons - President, CEO & Director Robert M.
